Latest total liabilities for TLSI: $56M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
TriSalus Life Sciences (TLSI) currently reports a total liabilities of $56M as of June 2026. That compares with $61M in the prior-year period — down 8.0% year over year. Use the charts on this page to explore TriSalus Life Sciences's total liabilities history and peer comparisons.
TriSalus Life Sciences's total liabilities decreased from $61M to $56M — a 8.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
TriSalus Life Sciences reported $56M in total liabilities as of June 2026. That compares with $61M in the prior-year period — down 8.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total liabilities of $56M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for TriSalus Life Sciences, and consider following TLSI for alerts when major investors trade the stock.